Keywords: biowa, acquires, anti-interleukin-5, receptor, antibody, rights, wholly-owned

BioWa acquires anti-interleukin-5 receptor antibody rights

Article | 04 April 2005

BioWa, a wholly-owned subsidiary of Japan's largest biotechnology company, Kyowa Hakko Kogyo, has obtained the ex-Asia commercialization and development rights ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Kyowa Hakko

Go to company listing